Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lydia Scarfò

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
The New England Journal of Medicine|December 8, 2025
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic LeukemiaOthman Al-Sawaf, Janina Stumpf, Can Zhang, et al.
American Journal of Hematology|February 26, 2020
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study groupYair Herishanu, Adir Shaulov, Riva Fineman, et al.
Blood Advances|October 24, 2025
Central Nervous System Involvement in CLL: An International Retrospective Study by ERIC, the European Research Initiative on CLLThomas Chatzikonstantinou, Mariia Mikhaleva, Christian Brieghel, et al.
Leukemia|June 30, 2025
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasmsFerran Nadeu, Shimin Shuai, Guillem Clot, et al.
Blood|September 29, 2020
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLLAndreas Agathangelidis, Anastasia Chatzidimitriou, Katerina Gemenetzi, et al.
Leukemia|July 11, 2020
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL CampusLydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin, et al.
Blood|October 15, 2021
Genetic and phenotypic attributes of splenic marginal zone lymphomaFerdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti, et al.
Journal of Hematology & Oncology|August 26, 2022
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLLDarko Antic, Natasa Milic, Thomas Chatzikonstantinou, et al.
Leukemia|November 2, 2021
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL studyThomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò, et al.
American Journal of Hematology|September 29, 2023
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLLAndrea Visentin, Thomas Chatzikonstantinou, Lydia Scarfò, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
The New England Journal of Medicine|December 8, 2025
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic LeukemiaOthman Al-Sawaf, Janina Stumpf, Can Zhang, et al.
American Journal of Hematology|February 26, 2020
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study groupYair Herishanu, Adir Shaulov, Riva Fineman, et al.
Blood Advances|October 24, 2025
Central Nervous System Involvement in CLL: An International Retrospective Study by ERIC, the European Research Initiative on CLLThomas Chatzikonstantinou, Mariia Mikhaleva, Christian Brieghel, et al.
Leukemia|June 30, 2025
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasmsFerran Nadeu, Shimin Shuai, Guillem Clot, et al.
Blood|September 29, 2020
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLLAndreas Agathangelidis, Anastasia Chatzidimitriou, Katerina Gemenetzi, et al.
Leukemia|July 11, 2020
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL CampusLydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin, et al.
Blood|October 15, 2021
Genetic and phenotypic attributes of splenic marginal zone lymphomaFerdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti, et al.
Journal of Hematology & Oncology|August 26, 2022
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLLDarko Antic, Natasa Milic, Thomas Chatzikonstantinou, et al.
Leukemia|November 2, 2021
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL studyThomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò, et al.
American Journal of Hematology|September 29, 2023
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLLAndrea Visentin, Thomas Chatzikonstantinou, Lydia Scarfò, et al.
Pageof 12